• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

About FDA

  • Print
  • Share
  • E-mail

Import Process - Considerations


Background

Summary of Public Comments

Transparency Report Arrow Considerations

View All Draft Proposals for This Topic


The Task Force agrees that FDA could improve its communications with importers in many of the ways proposed.  FDA agrees that where possible, and when appropriate, industry should be given the means to correct inadvertent data errors submitted about imported products.

In determining which actions would be most effective to improve transparency to importers, the Task Force considered the need for flexibility to adapt to local conditions as well as different FDA-regulated products, and the efficiencies that may result from a more uniform system.

The Task Force also considered the information currently provided to the importer community, and whether improvements in how that information is presented would improve transparency.  The Task Force considered whether the means available for the importing community to get information about importing requirements could be made more accessible.  The Task Force also considered the current responsibilities of FDA employees to protect the public health.  The Task Force sought to determine efforts that the agency could undertake to improve communication, given the agency’s competing priorities and limited resources.

Back to Import Process